Search

everythinglearnresearchcommunity

for

Search:↓

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Topical finasteride may help treat facial hirsutism in women.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Testosterone applied to rabbit skin increases skin cell growth and changes skin structure.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Dutasteride and finasteride affect different cell types differently.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Eating selenium-rich rice improved antioxidant activity and signs of aging in mice.